| Insights from global key opinion leaders on optimizing patient care in genitourinary malignancies | 04/14/2025 | |
| Guideline-recommended second-line treatment following an immune checkpoint inhibitor in renal cell … | 04/27/2025 | |
| Guideline-recommended first-line treatment with immunotherapy and targeted therapy combinations in … | 04/23/2025 | |
| Incorporation of guideline recommendations into the frontline care of a patient with mCRPC who is n… | 04/26/2025 | |
| Guideline recommendations for first-line treatment intensification with PARP inhibitor combinations… | 04/22/2025 | |
| Clinical evidence driving guideline recommendations for frontline immunotherapy-based combination r… | 04/26/2025 | |
| Innovations in Oncology Learning Center From Guidelines to Practice: Genitourinary Cancers | | |
